New laser resurfacing therapy promising for actinic keratoses

January 11, 2013
New laser resurfacing therapy promising for actinic keratoses
For patients with facial photodamage and actinic keratoses, treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial actinic keratoses and produces noticeable improvement in overall photodamage, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

(HealthDay)—For patients with facial photodamage and actinic keratoses (AK), treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial AK and produces noticeable improvement in overall photodamage, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

In an effort to evaluate the efficacy, safety, and tolerability of a fractional resurfacing technique that utilizes a nonablative 1927-nm thulium laser, Elliot T. Weiss, M.D., of the Laser & Skin Surgery Center of New York in New York City, and colleagues conducted a six-month prospective study involving 24 individuals with facial photodamage and AK. Patients received up to four treatments at two- to six-week intervals and were evaluated at one, three, and six months after the final treatment.

The researchers found that, at one month after the final treatment, there was a 91.3 percent reduction in the average number of facial AK from baseline (from 14.4 to 1.22). This effect was sustained at three and six months, with 87.3 and 86.6 percent reductions, respectively, in the absolute number of lesions. At six months, a marked or noticeable improvement in overall photodamage was reported.

"The clinical and histologic findings, as well as the reported patient satisfaction and safety, suggest that the of AK and photodamage with a fractionated 1927-nm nonablative thulium laser is a promising new therapeutic option," the authors write.

Two authors are investigators with Solta Medical, manufacturers of the laser used in the study.

Explore further: Fractional, ablative er:YAG laser akin for skin resurfacing

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Fractional, ablative er:YAG laser akin for skin resurfacing

November 10, 2012
(HealthDay)—Multiple sessions of fractional laser treatment with erbium:yttrium-aluminum-garnet (Er:YAG) for facial resurfacing are comparable to a single ablative Er:YAG laser treatment, according to a small study published ...

Safety, efficacy of at-home laser for periobital wrinkles studied

October 24, 2012
(HealthDay)—A handheld nonablative fractional laser is safe and seems effective for home use for treating periorbital wrinkles, according to a study published in the November issue of the Journal of the American Academy ...

Pulsed dye laser effective on port-wine stains in infants

February 28, 2012
(HealthDay) -- Pulsed dye laser (PDL) treatment at two-, three-, and four-week intervals is effective for infants with facial port-wine stains (PWS), with minimal short-term side effects, according to a study published online ...

Dual mode laser therapy effectively treats acne vulgaris

March 27, 2012
(HealthDay) -- A series of Nd:YAG laser treatments effectively and rapidly reduces both inflammatory and noninflammatory acne vulgaris lesions, according to a study published in the April issue of the Journal of the American ...

Diode laser efficient, safe for tonsillotomy in children

August 7, 2012
(HealthDay) -- A fiber-guided 1,470 nm diode laser system is safe and effective for tonsillotomy in the treatment of obstructive tonsillar hypertrophy in children, according to a study published online July 26 in Lasers in ...

Recommended for you

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.